Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT vs. AS and 3DCRT/IMRT followed by Chemotherapy with Docetaxel and Prednisone for Localized; High-Risk Prostate CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: RTOGStatus: Closed to Accrual. Pts Have Completed InterventionReview Status: Completed
